1. Home
  2. VSAT vs NVAX Comparison

VSAT vs NVAX Comparison

Compare VSAT & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSAT
  • NVAX
  • Stock Information
  • Founded
  • VSAT 1986
  • NVAX 1987
  • Country
  • VSAT United States
  • NVAX United States
  • Employees
  • VSAT N/A
  • NVAX N/A
  • Industry
  • VSAT Radio And Television Broadcasting And Communications Equipment
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • VSAT Technology
  • NVAX Health Care
  • Exchange
  • VSAT Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • VSAT 1.9B
  • NVAX 1.3B
  • IPO Year
  • VSAT 1996
  • NVAX 1995
  • Fundamental
  • Price
  • VSAT $14.60
  • NVAX $6.84
  • Analyst Decision
  • VSAT Buy
  • NVAX Buy
  • Analyst Count
  • VSAT 7
  • NVAX 5
  • Target Price
  • VSAT $20.00
  • NVAX $16.60
  • AVG Volume (30 Days)
  • VSAT 3.5M
  • NVAX 4.9M
  • Earning Date
  • VSAT 08-06-2025
  • NVAX 08-07-2025
  • Dividend Yield
  • VSAT N/A
  • NVAX N/A
  • EPS Growth
  • VSAT N/A
  • NVAX N/A
  • EPS
  • VSAT N/A
  • NVAX 2.97
  • Revenue
  • VSAT $4,519,571,000.00
  • NVAX $1,254,962,000.00
  • Revenue This Year
  • VSAT $4.46
  • NVAX $56.85
  • Revenue Next Year
  • VSAT $3.58
  • NVAX N/A
  • P/E Ratio
  • VSAT N/A
  • NVAX $2.30
  • Revenue Growth
  • VSAT 5.50
  • NVAX 25.92
  • 52 Week Low
  • VSAT $6.69
  • NVAX $5.01
  • 52 Week High
  • VSAT $26.70
  • NVAX $17.81
  • Technical
  • Relative Strength Index (RSI)
  • VSAT 60.99
  • NVAX 51.12
  • Support Level
  • VSAT $14.31
  • NVAX $6.54
  • Resistance Level
  • VSAT $16.20
  • NVAX $7.20
  • Average True Range (ATR)
  • VSAT 0.78
  • NVAX 0.28
  • MACD
  • VSAT -0.05
  • NVAX 0.06
  • Stochastic Oscillator
  • VSAT 53.27
  • NVAX 66.36

About VSAT ViaSat Inc.

Viasat Inc provides bandwidth technologies and services in three segments: communication services and defense and advanced technologies. The communication services segment provides a wide range of broadband and narrowband communications solutions across government and commercial mobility markets, as well as for residential and enterprise fixed broadband customers: and the defense and advanced technologies segment develops and offers a diverse array of resilient, vertically integrated solutions to government and commercial customers, leveraging core technical competencies in encryption, cyber security, tactical gateways, modems and waveforms. A large majority of the firm's revenue is generated from communication services segment.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: